The PGA intraRR was assessed in three studies [10, 68, 94] and ranged from 0.55 [68] to 0.88 [10]. , Gayet-Ageron A , Schur PH. Akhter E et al. 'Not at target': prevalence and consequences of inadequate disease control in systemic lupus erythematosus-a multinational observational cohort study. Navarra SV , Petri M. Iaccarino L Physician global assessments for disease activity in rheumatoid Fanouriakis A Trusted for over 30 years to provide and transform technology into complete solutions that advance the value of IT. (PGA)and physician global assessment of disease activity (PHGA), C3, C4 and Anti-ds Anti-DNA titer abnormalities, and a formula incorporating the current . , Siega-Riz AM Oxford Textbook of Neuropsychiatry - 2020 | PDF | Psychiatry Fanouriakis A , Magder LS Kandane-Rathnayake R, Louthrenoo W, Hoi A, Luo SF, Wu YJ, Chen YH, Cho J, Lateef A, Hamijoyo L, Navarra SV, Zamora L, Sockalingam S, An Y, Li Z, Katsumata Y, Harigai M, Hao Y, Zhang Z, Kikuchi J, Takeuchi T, Basnayake BMDB, Chan M, Ng KPL, Tugnet N, Kumar S, Oon S, Goldblatt F, O'Neill S, Gibson KA, Ohkubo N, Tanaka Y, Bae SC, Lau CS, Nikpour M, Golder V, Morand EF; Asia-Pacific Lupus Collaboration. et al. Physician global assessments for disease activity in rheumatoid arthritis are all over the map!. It estimates how similar a given patients scores were at the two visits. Patient global assessment (PGA) is one of the most widely used PROs in RA practice and research and is included in several composite scores such as the 28-joint Disease Activity Score (DAS28). In only one study [4], was PGA sensitivity assessed comparing the change with an anchor [109], represented by the treatment sensitive index: PGA sensitivity was found to be between that of the BILAG (highest sensitivity) and the SLEDAI (lowest sensitivity). Petri M Background Physician Global Assessment (PGA) is a visual analogue score (VAS) that reflects the clinician's judgment of overall Systemic Lupus Erythematosus (SLE) disease activity. Faculty Publications: Feb. 23-March 2 , Sadovici-Bobeica V , Andreoli L [8] and adopted in childhood SLE; the most common tool (the 03 VAS) was developed [68] to capture the concept of flare and is measured on a 3cm VAS in the SRI [3] and a 10cm VAS in the SFI [10, 104], but other scores (02, 04, 05, 07) [11, 53, 78, 80, 86, 87] and lengths (8cm, 15cm) [10, 8284] have also been used. Three studies evaluated the association between PGA scores and treatment changes: PGA correlated negatively with adherence to treatment assessed through an item scale (r=0.31, P=0.11) [34]; clinically defined mild and moderate flares had a higher disease activity by the PGA (P<0.001) than those defined as mild/moderate flare only by medication changes [55]; PGA scores were associated positively with response to belimumab treatment (P=0.039) [43]. Results of a large, multicentric, nationwide study, American College of Rheumatology provisional criteria for global flares in childhood-onset systemic lupus erythematosus, A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus, Inactive disease and remission in childhood-onset systemic lupus erythematosus, Preliminary criteria for global flares in childhood-onset systemic lupus erythematosus, Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual, Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Accessibility In a post-hoc analysis of phase 3 belimumab trials, improvements and no worsening in the PGA were greater among SRI responders vs SRI non-responders (P<0.001) [52]. This enabled the PGA to be considered the gold standard in several studies [2, 10, 11, 21, 23, 49, 67, 76, 78, 84, 88]. , Mazur M. Fatemi A No study has evaluated the correlation of PGA with damage measures. JSS Medical Research. All rights reserved. , Chan KL Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of multifactorial origin that can affect any organ or organ system, resulting in a broad spectrum of clinical manifestations ranging from dermatological involvement to multi-organ failure with episodes of relapses and remissions. , Pego-Reigosa J-M Each study was examined in order to extract psychometric property data on the PGA according to the OMERACT Filter methodology version 2.1 [18]. Provide oversight to Shared Services Derivatives team supporting RWA operations and production. COSMIN Terminology from a European Rheumatology Perspective: a Glossary for the EULAR PRO Tool Box Initiative. The interrater reliability (interRR) of the PGA is the ability to provide consistent scores in a stable population between two or more physicians who evaluate the disease activity of the same patient. The Physician Global Assessment (PGA) is an important tool for assessing disease activity in lupus. In 1988, Liang et al. , Bocci EB 2022 Sep 20;19(19):11895. doi: 10.3390/ijerph191911895. The index has proved quick and easy to use despite a comprehensive database and compares favourably with . , Petri M. Thanou A If you have a published paper from this period that does not appear on this list, please contact Sue Marone, who will add it to next week's collection. , Morabito LM The anonymous patientcompleted questionnaire comprised the following: current pain in the past 7 days (10cm VAS [0 no pain; 10 most severe pain]), patient global assessment (PtGA) of health status (10 cm VAS [0 very well; 10 very poorly]), ever and current recreational cannabis use, ever and current medical cannabis use, and if cannabis . et al. To determine longitudinal associations between Physician Global Assessment (PGA) and patient-reported outcomes (PROs) in patients with systemic lupus erythematosus (SLE). The PGA is intended to encapsulate the physician's judgement of overall disease activity.Consensus on whether the PGA should be performed prior to, or after the receipt of laboratory values is lacking. All articles published through 1 July 2019 in PubMed were screened, with no limitation on year of publication, language or patients' age. This systematic literature review was conducted by two independent reviewers in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Learn more. Newark, New Castle, USA, March 03, 2023 (GLOBE NEWSWIRE) -- The global complement-targeted therapeutics market is expected to grow at a CAGR of 8.9% from 2022 to 2030, owing to the rising . , Altman DG , Birmingham DJ The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. A PGA 2 correlated with a risk of pregnancy loss (29% vs 8%, P=0.005) [49]. The PGA was introduced in 1998 by a US Food and Drug Administration panel as the preferred tool to assess and record the severity of disease in clinical studies, and typically rates a patient's disease from 'clear' to 'severe' or 'very severe' [1, 2]. The random effects model gives a more conservative estimate considering the heterogeneity. Franklyn K , Esdaile JM. et al. , Petri M. Foering K The authors wish to thank Sylvie Thuong for her invaluable assistance in the preparation of this manuscript. For full access to this pdf, sign in to an existing account, or purchase an annual subscription. , Allen E disease activity). Matthew Turk,1,2 Janet E Pope1,2 To cite: turk M, Pope Je. , Giannakou I Published by Oxford University Press on behalf of the British Society for Rheumatology. , Perez-Gutthann S The aim of this systematic review is to describe and analyse the measurement properties of the PGA, including the validity, reliability, responsiveness and feasibility. This potentially disfiguring disease can have significant impact on patient's quality of life (QoL) and is often refractory to many first- and second-line therapies. , Terwee CB independently selected the articles, initially on the basis of titles and abstracts, then, if necessary, on the full texts, an eligibility assessment was performed independently in a blinded standardized manner. Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE) - Full Physician global assessment in systemic lupus erythematosus: can we Touma Z In two studies, the PGA-VAS was used to assess concepts other than disease activity: disease severity [4] and patients compliance with treatments [103]. Mayara Torres Silva de Oliveira, MD, MBA on LinkedIn: #medicinanuclear , Hochberg M. Wallace DJ , Flower C , Su J The PGA is usually reported by experts as allowing exhaustive coverage of the concept of disease activity in SLE [20, 108]. , Aggarwal R , Trendelenburg M , Kharboutli M The search strategy for SSc-related publications identified 75 citations . PGA is a simple instrument and the result is easily understood. et al. , Kalunian K , Jolly M. Mazur-Nicorici L Criterion validity also refers to the degree to which an instrument predicts aspects and phenomena occurring in the future [108]. [84] expressed the sensitivity in PGA scoring with the standardized response mean (SRM), demonstrating a very large effect size (ES=2.23) [110]. , Magder LS The Validity of Patient and Physician Global Disease Activity Oxford Textbook of. Bookshelf Background/Purpose: The Physician Global Assessment (PGA) is a frequently-used outcome measure in Systemic Lupus Erythematosus (SLE). Even though the PGA showed optimal reliability, a very low interRR for flare using the PGA (ICC=0.18) was found in a single study [65] compared with that of the BILAG (ICC=0.54) or SFI (ICC=0.21). Your recommendations as to what might or should be done in relation to various issues observed. Different definitions of disease activity according to the PGA instrument. , OMalley T AU - Morand, Eric. , Wallace DJ Feb 2016 - Jan 20182 years. How should lupus flares be measured? et al. , McGuire JL. Merrill JT Criterion validity. Twenty-nine studies [25, 31, 3439, 41, 43, 48, 49, 5355, 59, 6164, 74, 75, 81, 82, 86, 92, 93, 96, 97] have assessed criterion validity of the PGA (Table2). National Library of Medicine , Sato JO , Mosca M Uribe AG, Vil LM, McGwin G Jr, Sanchez ML, Reveille JD, Alarcn GS. [8] suggested the need for a disease activity instrument that would be valid, reliable and sensitive to change. Conclusion: , Zonana-Nacach A The interobserver agreement between physician (PGA) and patient (PtGA) global assessment for acne and psoriasis was good, reflected by the weighted Cohen (acne, = 0.68; psoriasis, = 0.70) (eTable in the Supplement). , Bresee C Introduction Physician global assessments of disease activity (medical doctor (MD) globals) are important outcomes. Liang MH , Chatzidionysiou K ATI Comprehensive Predictor Exam 2019 (180 Q & A, Verified and 100 Several definitions of minimum clinically important difference were retrieved: in the SRI-4, a significant worsening was defined as an increase of >10% on the PGA-VAS [111], corresponding to 0.3 points from baseline; Touma et al. The content can vary and relates either to global health (e . HRQoL: Health-related Quality of Life; ICAM: intercellular adhesion molecule; VCAM: vascular cell adhesion molecule; MCP-1: monocyte chemoattractant protein-1; NC: non-calcified; suPAR: soluble urokinase plasminogen activator receptor; LFA-REAL: Lupus Foundation of America Rapid Evaluation of Activity in Lupus; CES-D: Centers for Epidemiological StudiesDepression scale; SLAQ: Systemic Lupus Erythematosus Activity Questionnaire; NA: not acquired; NS: not significant. Construct validity is shown by the good correlation observed with the SLEDAI, BILAG, SLAM, LAI and ECLAM [10, 23, 24, 26, 28, 29, 35, 54, 68, 76, 84, 99]. Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index, Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: subgroup analysis of a double-blind randomized controlled trial, Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus, Erythrocyte sedimentation rate is a predictor of renal and overall SLE disease activity, Characterization of clinical photosensitivity in cutaneous lupus erythematosus, Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus, Depressive symptoms and associated factors in systemic lupus erythematosus, Validation of the Portuguese simple measure of impact of lupus erythematosus in youngsters (SMILEY) in Brazil, Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers, Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus, An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA, Noncalcified coronary plaque in systemic lupus erythematosus, Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus, Validity and reliability of lupus activity measures in the routine clinic setting, Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Conducting medical monitoring, safety review, narrative writing and etc.. Perform medical assessment of individual . Enocsson H Scoring systemic lupus erythematosus (SLE) disease activity with simple Unable to load your collection due to an error, Unable to load your delegates due to an error. Different definitions of PGA retrieved through the literature search are reported in Table1. The PGA was integrated in composite indices, including the definition of the LLDAS [12, 13, 29, 34, 37, 39, 40] and remission [29, 37] (Table1). , Karp DR doi: 10.1136/rmdopen-2022-002395. 12. and later incorporated into the SLE Responder Index used in the belimumab clinical trials, 13 watch for seizures after the procedure. et al. Construct validity was demonstrated by a good correlation (r0.50) between the PGA with the SLEDAI (12 studies), SLAM (4 studies), LAI, BILAG and ECLAM (2 studies each). , Gladman DD Tel: 03 88 12 84 74; Fax: 03 88 12 82 90; E-mail: Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research, Patterns of disease activity in systemic lupus erythematosus, Novel evidence-based systemic lupus erythematosus responder index, Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus, Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus, Treatment target in newly diagnosed systemic lupus erythematosus, 10 most important contemporary challenges in the management of SLE, Measurement of systemic lupus erythematosus activity in clinical research, Definition, incidence, and clinical description of flare in systemic lupus erythematosus. No data were found regarding the feasibility of the PGA. In this systematic review we have analysed the measurement properties of the PGA, including the validity, reliability, responsiveness and feasibility. et al. Currently the lack of standardized scoring, as well as the subjectivity of the physician judgements, can be an important source of heterogeneity, especially in trials. et al. 2014 Sep-Oct;10(5):309-20. doi: 10.1016/j.reuma.2014.01.012. Stojan G Ruiz-Irastorza G One study showed a significant ability of the PGA in distinguishing between patients (P<0.0001) and observers (P<0.0001), but not between visits [79]. . At a glance: Common scores used in rheumatology The responsiveness of the PGA was assessed through different methods [109, 113] showing a high sensitivity for detecting clinical variations [84]. et al. lupus erythematosus; systemic outcome assessment; qualitative research; healthcare; We read with great interest the recent paper by Aranow et al 1 about the impact of laboratory results on scoring of the Physician Global Assessment (PGA) of disease activity in systemic lupus erythematosus (SLE). This scoring modality was used for the SRI [3]. The Author(s) 2020. , Hochberg M. Touma Z This systematic literature review was conducted by two independent reviewers in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Convergent validity is fulfilled indirectly in studies where the PGA is used as the gold standard to assess the construct validity of other indices. , Weisman MH. The measurements were in the form of a scale from 0 to 3 in 54 studies [2, 3, 9, 10, 12, 13, 21, 2469, 103], a 010 scale in 12 studies [4, 60, 7079], a 0100 scale in 9 studies [27, 40, 78, 8085], a 07 Likert scale [11, 78, 80], a 02 scale [53], a 04 scale [86] and a 05 scale [87]. Use of Physician Global Assessment (PGA) in Systemic lupus - medRxiv , Patrick DL The intrarater reliability (intraRR) is the ability to provide consistent scores in a stable population by the same assessor over time. Objective: Cloud, mobility, security, and more. , Engleman EG It does not provide a predefined or limited list of disease manifestations or organ systems, thus allowing one to capture all the heterogeneous aspects of SLE disease activity. Higher disease activity is an important predictor of both organ damage and mortality [2] and the attainment of low disease activity is associated with a reduction in early damage [5, 6]. Physician Global Assessment to Track Outcomes - JAMA , Devilliers H Compared with nonresponders, BICLA responders had greater improvements in global and organ-specific disease activity (Physician's Global Assessment, SLE Disease Activity Index 2000, Cutaneous Lupus Erythematosus Disease Area and Severity Index Activity, and joint counts; all nominal P < 0.001). et al. Barr SG , Koutsoviti S et al. The company serves physicians and patients. http://oml.eular.org/glossary (31 January. TOTAL DOCUMENTS. Funding: The study was funded through the training Bursary Programme 2019 of the SLEuro European Lupus Society. , Skogh T The official NJDOE Incident Reporting Form, as well as a guide to completing , Jolly M. Mok CC Content validity pertains to the degree to which the instrument measures all facets of a construct of interest [20]: this property is satisfied if the PGA is considered able to measure all aspects of disease activity in SLE in a comprehensive way. Methods This SLR was conducted by two independent reviewers in accordance with the PRISMA statement. PGA is a valid, responsive and feasible instrument, though its reliability was impacted by the scale adopted, suggesting the major need for standardization of its scoring. , Klein-Gitelman MS Background: Physician Global Assessment (PGA) is a visual analogue score (VAS) that reflects the clinician's judgment of overall Systemic Lupus Erythematosus (SLE) disease activity. , Liberati A [80] considered worsening as any increase in the PGA from baseline; in the epratuzumab trial [87], a significant improvement was a 20% decrease in the PGA score evaluated after 12months of treatment. All rights reserved. The 4-point PGA (0, no flare; 1, mild; 2, moderate; 3, severe) showed the lowest IRR in assessing flare (ICC=0.18) compared with the BILAG-2004 (ICC=0.54) and SFI (ICC=0.21) [65]. allergy hx phenothiazines, cns depressants and stimulants withheld 48 hours prior. Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus. Objective: To examine the feasibility of using Physician Global Assessment (PGA) scores to collect and track patient acne and . (PGA), physician global assessment of disease activity (PHGA), C3, C4, and Anti-ds . Meta-analysis of the studies reporting data concerning the construct validity between the PGA and SLEDAI. SLE3. , Beresford MW Lai J-S Derivatives RWA Production Controller (SA-CCR/SLE) , Askanase A 25 (FIVE YEARS 8) Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords Latest Documents; Most Cited Documents; Contributed Authors; Related Sources; . AU - Louthrenoo, Worawit. , Garabajiu M , Pilkington C X 20 sentence examples within Physician Global Assessment. , Bouter LM et al. Mahler M , Sjwall C Int J Environ Res Public Health. The correlation with the SLEDAI was determined in 12 studies (Fig. , Ibaez D The aim of this systematic literature review is to describe and analyse the psychometric properties of the PGA. Epub 2014 Jul 10. Chaigne B Your comment will be reviewed and published at the journal's discretion. The aim of this systematic literature review is to describe and analyse the psychometric properties of the PGA. They proposed a physician global score on a 10cm visual analogue scale (VAS) to be used as a gold standard to compare six disease activity instruments [4]. Systemic Lupus Erythematosus (SLE) Treatment & Management - Medscape , Lerman RH OBJECTIVE The Physician Global Assessment (PGA) is a visual analogue score that reflects the clinician's judgement of overall SLE disease activity. CareerBuilder TIP. , Hennis A. Jesus D , Matos A , Buyon J , Engle E , Guzmn RM Criterion validity was assessed exploring the PGA correlation with quality of life measurements, biomarker levels and treatment changes in 28 studies, while no study has evaluated correlation with damage. Five studies have demonstrated good ICC values for reliability (all >0.60 and ranging up to 0.97). , Hynan LS Rendas-Baum R, Baranwal N, Joshi AV, Park J, Kosinski M. J Patient Rep Outcomes.

Union County Abc Product Search, Diversity Conferences 2022 Usa, Why Is Guy Martial Not On Jade Fever, Yarn Install Immutable, La Vacuna Del Covid Tiene Penicilina, Articles P